Skip to main content
STAA
NASDAQ Industrial Applications And Services

STAAR Surgical Projects Q1 Net Sales Over $90M, Signaling Strong Rebound and Profit Improvement

Arie Shkolnikov · Analysis by Wiseek AI
More coverage: Medical Instrument Stocks · Healthcare
Sentiment info
Positive
Importance info
8
Price
$25.53
Mkt Cap
$1.034B
52W Low
$14.69
52W High
$30.81
52W Position info
74% above low
Off High info
17% below high
Rel. Volume info
0.7× avg
Market data snapshot near publication time

STAA sits 74% above its 52-week low of $14.69.

Summary

STAAR Surgical announced preliminary Q1 2026 net sales are expected to exceed $90 million, more than doubling Q1 2025 sales and indicating a significant operational turnaround after a challenging prior year.


Key Events · Earnings and Guidance · STAA

  • Preliminary Q1 2026 Net Sales Exceed Expectations

    The company expects net sales for the first quarter of 2026 to be over $90 million, a substantial increase from $42.6 million in Q1 2025.

  • Significant Operational Turnaround

    This strong performance, driven by growth in China and the Americas, follows a challenging fiscal year 2025 which saw a 23.7% sales drop and a widened net loss.

  • Expected Profitability Improvement

    Higher net sales combined with an improved cost structure are anticipated to lead to a meaningful improvement in adjusted EBITDA for the quarter.

  • Addresses Strategic Objectives

    These results deliver on the company's core objectives of 'Revenue Growth and Profit Expansion' outlined earlier this year.


Analysis · STAA · Industrial Applications And Services

STAAR Surgical's preliminary Q1 2026 net sales exceeding $90 million represents a significant operational turnaround, more than doubling the $42.6 million reported in Q1 2025. This positive development follows a challenging fiscal year 2025, which saw a substantial 23.7% drop in net sales and a widened net loss, alongside a terminated merger agreement and leadership changes. The strong performance, primarily driven by growth in China and the Americas, is expected to lead to a meaningful improvement in adjusted EBITDA, addressing key strategic objectives of revenue growth and profit expansion. While the company notes volatile global conditions and declines in some EMEA and APAC regions, the overall preliminary results indicate a robust recovery from previous difficulties.

At the time of this filing, STAA was trading at $25.53 on NASDAQ in the Industrial Applications And Services sector, with a market capitalization of approximately $1B. The 52-week trading range was $14.69 to $30.81. This filing was assessed with positive market sentiment and an importance score of 8 out of 10.

View Main SEC Filing

Price Chart

Share this article

Copied!

STAA - Latest Insights

STAA
Jul 16, 2026, 6:04 PM EDT
Source: Dow Jones Newswires
Importance Score:
8
Price at Filing: $25.59
Real-time Price: $22.68 info
Change: -$2.91 (-11%) info
Market Cap: $1.128B info
STAA
Jul 16, 2026, 4:01 PM EDT
Source: BusinessWire
Importance Score:
8
Price at Filing: $28.98
Real-time Price: $22.68 info
Change: -$6.30 (-22%) info
Market Cap: $1.128B info
STAA
Jun 22, 2026, 4:05 PM EDT
Filing Type: 8-K
Importance Score:
8
Price at Filing: $28.83
Real-time Price: $22.68 info
Change: -$6.15 (-21%) info
Market Cap: $1.128B info
STAA
May 13, 2026, 4:06 PM EDT
Filing Type: 10-Q
Importance Score:
9
Price at Filing: $34.68
Real-time Price: $22.68 info
Change: -$12.00 (-35%) info
Market Cap: $1.128B info
STAA
May 13, 2026, 4:02 PM EDT
Filing Type: 8-K
Importance Score:
9
Price at Filing: $32.14
Real-time Price: $22.68 info
Change: -$9.46 (-29%) info
Market Cap: $1.128B info